Personal information

No personal information available

Activities

Collapse all

Works (8)

Post-transplant cyclophosphamide with post-engraftment anti-thymocyte globulin reduce moderate to severe chronic graft-versus-host disease in peripheral stem cell transplantation from HLA-matched unrelated and haploidentical donors

Bone Marrow Transplantation
2025-01 | Journal article
DOI: 10.1038/s41409-024-02436-7
Contributors: Ying Wang; Wen-Hui Gao; Li-ning Wang; Ling Wang; Jie-ling Jiang; Ming Wan; Ai-Bin Liang; Didier Blaise; Jiong Hu
Source: check_circle
Crossref

Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis

Bone Marrow Transplantation
2024-10 | Journal article
DOI: 10.1038/s41409-024-02371-7
Contributors: Lining Wang; Wenhui Gao; Ling Wang; Jieling Jiang; Ming Wan; Didier Blaise; Jiong Hu
Source: check_circle
Crossref

Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning

Bone Marrow Transplantation
2024-07 | Journal article
DOI: 10.1038/s41409-024-02277-4
Contributors: Lining Wang; Guilin Xu; Ling Wang; Jieling Jiang; Wenhui Gao; Ming Wan; Didier Blaise; Jiong Hu
Source: check_circle
Crossref

Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation

Blood Cancer Journal
2024-07-08 | Journal article
DOI: 10.1038/s41408-024-01092-w
Contributors: Jiayu Huang; Bingyang Shi; Suhui Yu; Mengxing Xue; Ling Wang; Jieling Jiang; Jiong Hu; Jun Zhu; Suning Chen; Lijing Shen et al.
Source: check_circle
Crossref

Post-transplant cyclophosphamide at 80mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning

2023-12-15 | Preprint
DOI: 10.21203/rs.3.rs-3737986/v1
Contributors: Jiong Hu; Lining Wang; Guilin XU; Ling WANG; Jieling Jiang; Wenhui GAO; Ming Wan; Didier Blaise
Source: check_circle
Crossref

Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients

Transplantation and Cellular Therapy
2023-08 | Journal article
DOI: 10.1016/j.jtct.2023.05.017
Contributors: Jie-ling Jiang; Wen-hui Gao; Li-ning Wang; Ming Wan; Ling Wang; Jiong Hu
Source: check_circle
Crossref

Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial

Bone Marrow Transplantation
2022-06 | Journal article
DOI: 10.1038/s41409-022-01639-0
Contributors: Ling Wang; Wenhui Gao; Lining Wang; Min Wan; Jieling Jiang; Jiong Hu
Source: check_circle
Crossref

Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study

Bone Marrow Transplantation
2022-05 | Journal article
DOI: 10.1038/s41409-022-01643-4
Contributors: Jie-ling Jiang; Ming Chen; Li-ning Wang; Min Wan; Wen-hui Gao; Ling Wang; Jiong Hu
Source: check_circle
Crossref

Peer review (8 reviews for 2 publications/grants)

Review activity for Bone marrow transplantation (7)
Review activity for Cell death and disease. (1)
How many people are using ORCID?